Notice2024-12835
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 12, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 114 (Wednesday, June 12, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 114 (Wednesday, June 12, 2024)]
[Notices]
[Page 49888]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-12835]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; R13 Conference Grant Review.
Date: July 24, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Xiaozhong Alex Bao, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W552, Rockville, Maryland 20850, 240-276-5070,
<a href="/cdn-cgi/l/email-protection#4200232d3a022f232b2e6c2c2b2a6c252d34"><span class="__cf_email__" data-cfemail="bcfeddd3c4fcd1ddd5d092d2d5d492dbd3ca">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Advanced Development of Cancer Technologies.
Date: July 25-26, 2024.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850, 240-276-6371,
<a href="/cdn-cgi/l/email-protection#b0d4d5d3dcc5d5daf0ddd1d9dc9eded9d89ed7dfc6"><span class="__cf_email__" data-cfemail="432726202f362629032e222a2f6d2d2a2b6d242c35">[email protected]</span></a>.
Name of Committee: National Cancer Institute Initial Review
Group; Cancer Centers Study Section (A).
Date: August 15, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W110, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Caterina Bianco, M.D., Ph.D., Chief, Scientific
Review Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W110, Rockville, Maryland 20850, 240-276-6459,
<a href="/cdn-cgi/l/email-protection#2e4c474f404d414d6e434f47420040474600494158"><span class="__cf_email__" data-cfemail="5b39323a353834381b363a323775353233753c342d">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: June 6, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-12835 Filed 6-11-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 12, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.